Pages that link to "Q35456945"

The following pages link to Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors (Q35456945):

Displaying 28 items.

• Emerging therapeutic targets in esophageal adenocarcinoma (Q26751209) (← links)
• Technologies for deriving primary tumor cells for use in personalized cancer therapy (Q26829581) (← links)
• Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27. (Q34490253) (← links)
• The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells (Q35677831) (← links)
• A New Era for the Systemic Therapy of Neuroendocrine Tumors (Q35863865) (← links)
• Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors (Q36831577) (← links)
• Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression (Q37362571) (← links)
• The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer (Q37381494) (← links)
• The Role of Cell Lines in the Study of Neuroendocrine Tumors (Q38005913) (← links)
• Profiling of ileal carcinoids (Q38044219) (← links)
• Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems (Q38076275) (← links)
• Stem cells and cancer stem-like cells in endocrine tissues (Q38084129) (← links)
• Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. (Q38203882) (← links)
• Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors (Q38331666) (← links)
• Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor. (Q38703130) (← links)
• Rapamycin inhibited the function of lung CSCs via SOX2. (Q38822762) (← links)
• Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma (Q38850277) (← links)
• Fatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines (Q40978818) (← links)
• The genomic landscape of small intestine neuroendocrine tumors (Q41286943) (← links)
• Distinct prognostic values of ALDH1 isoenzymes in breast cancer (Q41591538) (← links)
• Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer. (Q42319926) (← links)
• Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway. (Q47224069) (← links)
• Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets (Q47393972) (← links)
• Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). (Q51225473) (← links)
• Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models. (Q52625303) (← links)
• Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift. (Q55313360) (← links)
• Profiling of GEPNETs (Q58693024) (← links)
• Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer (Q92740638) (← links)